Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,679 annual reports · 4,010 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 37 of 640 · 7,679 filings

  • ENvue Medical (FEED) FY2025 10-K risk factors
    68 risks9 new29 dropped19 reworded

    Merger integration and post-merger operations create significant stock volatility and business uncertainties for NanoVibronix and ENvue Holdings. Financing restrictions, preferred stock conversions, and cumulative dividend requirements risk severe shareholder dilution. Ongoing arbitration awards totaling $2.3 million to Protrade threaten company liquidity and financial condition.

    Filed Apr 15, 2026
  • Deep Fission (FISN) FY2025 10-K risk factors
    61 risks

    The business is pre-commercial, unproven, and has not generated commercial revenue.

    Filed Apr 15, 2026
  • Starfighters Space (FJET) FY2025 10-K risk factors
    36 risks

    Starfighters Space faces intense going concern risks due to generating under $1 million annually and needing massive capital investment. The company depends heavily on unproven technologies like the StarLaunch rocket family and payload platform. Executive leadership transitions, specifically CEO Rick Svetkoff's February 2026 resignation and replacement by Tim Franta, create key personnel dependencies.

    Filed Apr 15, 2026
  • Flash Sports & Media Holdings (FLZH) FY2025 10-K risk factors
    35 risks

    Flash Sports & Media relies heavily on its Sri Lanka Cricket contract for revenue, which creates extreme geographic and customer concentration risk. The company faces severe going concern doubts, minimal cash reserves of $10,000, and massive working capital deficits. Recent mergers and expansions into international cricket leagues have left the combined entity with substantial liabilities and Nasdaq listing compliance hurdles.

    Filed Apr 15, 2026
  • FRP Holdings (FRPH) FY2025 10-K risk factors
    22 risks3 new2 dropped2 reworded

    Real estate investments expose the company to construction, labor, material, and capitalization rate risks. Geographic exposure spans Baltimore, Washington D.C., and Greenville, South Carolina. Executive Chairman John D. Baker II and family control a significant percentage of common stock.

    Filed Apr 15, 2026
  • Flexible Solutions International (FSI) FY2025 10-K risk factors
    15 risks1 reworded

    International revenue percentage dropped significantly from 24% in 2024 to 16% in 2025.

    Filed Apr 15, 2026
  • GeoVax Labs (GOVX) FY2025 10-K risk factors
    33 risks1 new1 dropped3 reworded

    GeoVax added regulatory exclusivity risks under the BPCIA, dropped Nasdaq listing compliance, disclosed cash runway into mid-Q2 2026, and updated warrant figures.

    Filed Apr 15, 2026
  • Hyperscale Data (GPUS) FY2025 10-K risk factors
    206 risks120 new11 dropped19 reworded

    The company faces significant new risks from its Bitcoin treasury strategy and its Omnipresent robotics subsidiary. Regulatory scrutiny increases across Bitcoin holdings, CFTC compliance, and international tariffs on TurnOnGreen. BNC platform operations shifted focus from social gaming sweepstakes to predictions markets.

    Filed Apr 15, 2026
  • Hall Chadwick Acquisition (HCACR) FY2025 10-K risk factors
    76 risks

    This is an initial filing for a blank check company with no prior year risk factors. The risk profile is dominated by blank check company mechanics, potential conflicts of interest among sponsor affiliates, redemption rights, and going concern doubts.

    Filed Apr 15, 2026
  • Healthcare Triangle (HCTI) FY2025 10-K risk factors
    41 risks1 new2 dropped3 reworded

    SecureKloud dependency risks were revised to focus on potential delivery issues and less favorable third-party terms. Customer concentration figures shifted, with the top customer rising from 17 percent to 20 percent of revenue in 2025.

    Filed Apr 15, 2026
  • KALA BIO (KALA) FY2025 10-K risk factors
    66 risks23 new25 dropped18 reworded

    KALA BIO pivoted its business strategy toward AI-powered life sciences platforms, specifically licensing Researgency and shifting away from clinical biologics development.

    Filed Apr 15, 2026
  • Nauticus Robotics (KITT) FY2025 10-K risk factors
    73 risks16 new3 dropped15 reworded

    Nauticus Robotics faces heightened risks from international expansion in the UAE and Brazil amid Middle East military conflict. The company reported material weaknesses in financial controls and software/hardware vulnerabilities in ocean robotics. Federal net operating loss carryforwards increased to approximately $157 million.

    Filed Apr 15, 2026

Companies covered

4,010 companies

371 more under A